TScan Therapeutics, Inc.

DC Funds, LP TCRX
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/14/2026
Shares
630,000
Value ($000)
630,000
Weight
42.4%
2025 Q2 - 2026 Q1 (4 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).